XML 227 R78.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation - Summary of Activity Under Stock Option Plan (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]      
Outstanding, Beginning Balance (in shares) 4,173,168 4,564,735  
Granted (in shares) 600,000 100,000  
Stock option exercised (in shares) (253,335) 0  
Expired (in shares) (2,035,966) (486,666)  
Forfeited (in shares) (29,167) (4,901)  
Outstanding, Ending Balance (in shares) 2,454,700 4,173,168 4,564,735
Vested and exercisable as of December 31, 2021 (in shares) 1,848,033    
Weighted Average Exercise Price      
Outstanding Weighted Average Exercise Price, Beginning Balance $ 6.83 $ 8.54  
Weighted Average Exercise Price, Granted 3.22 3.45  
Weighted Average Exercise Price, Exercised 1.31   $ 1.31
Weighted Average Exercise Price, Expired 9.14 13.82  
Weighted Average Exercise Price, Forfeited 5.89 6.57  
Outstanding Weighted Average Exercise Price, Ending Balance 4.62 $ 6.83 $ 8.54
Weighted Average Exercise Price, Vested and exercisable as of end of period $ 5.06    
Weighted -Average Remaining contractual Term (in years)      
Weighted Average Remaining Contractual Term (in years), Outstanding as Beginning of period 4 years 6 months 29 days 3 years 6 months 29 days 5 years 1 month 2 days
Weighted Average Remaining Contractual Term (in years), Outstanding as of end of period 4 years 6 months 29 days 3 years 6 months 29 days 5 years 1 month 2 days
Weighted Average Remaining Contractual Term (in years), Vested and exercisable as of end of period 3 years 2 months 1 day    
Additional disclosures      
Aggregate Intrinsic Value, Outstanding as of beginning of period $ 1,324 $ 4,513  
Aggregate Intrinsic Value, Outstanding as of end of period 109 $ 1,324 $ 4,513
Aggregate Intrinsic Value, Vested and exercisable as of end of period $ 109